Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Construction in Progress (2017 - 2022)

Historic Construction in Progress for Marimed (MRMD) over the last 6 years, with Q1 2022 value amounting to $3.6 million.

  • Marimed's Construction in Progress fell 2427.08% to $3.6 million in Q1 2022 from the same period last year, while for Mar 2022 it was $3.6 million, marking a year-over-year decrease of 2427.08%. This contributed to the annual value of $10.6 million for FY2021, which is 23648.52% up from last year.
  • Per Marimed's latest filing, its Construction in Progress stood at $3.6 million for Q1 2022, which was down 2427.08% from $10.6 million recorded in Q4 2021.
  • Marimed's Construction in Progress' 5-year high stood at $12.2 million during Q4 2018, with a 5-year trough of $1.1 million in Q1 2019.
  • In the last 5 years, Marimed's Construction in Progress had a median value of $3.6 million in 2022 and averaged $5.5 million.
  • In the last 5 years, Marimed's Construction in Progress tumbled by 7704.92% in 2019 and then skyrocketed by 23648.52% in 2021.
  • Over the past 5 years, Marimed's Construction in Progress (Quarter) stood at $12.2 million in 2018, then plummeted by 77.05% to $2.8 million in 2019, then rose by 12.18% to $3.1 million in 2020, then soared by 236.49% to $10.6 million in 2021, then crashed by 65.61% to $3.6 million in 2022.
  • Its Construction in Progress stands at $3.6 million for Q1 2022, versus $10.6 million for Q4 2021 and $8.9 million for Q3 2021.